In today’s briefing:

– China Mobile (600941 CH): Potential Index Fast Entry

– 1H22 Obex Research Long Portfolio

– Shanghai Junshi Bioscience (1877.HK/688180.CH) – Behind the “break Up” with AstraZeneca

– Morning Views Asia: China Jinmao Holdings, China SCE, Guangzhou R&F Properties

Before it’s here, it’s on Smartkarma…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.